Article
Combining TP53 mutation and isoform has the potential to improve clinical practice.
Pathology - 1 Jun 2024
Ray Das Sankalita, Delahunt Brett, Lasham Annette, Li Kunyu, Wright Deborah, Print Cristin, Slatter Tania, Braithwaite Antony, Mehta Sunali
Abstract excerpt
The clinical importance of assessing and combining data on TP53 mutations and isoforms is discussed in this article. It gives a succinct overview of the structural makeup and key biological roles of the isoforms. It then provides a comprehensive summary of the roles that p53 isoforms play in cancer development, therapy response and resistance. The review provides a summary of studies demonstrating the role of p53...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
